Table 2.
Demographics of study participants
| NF1 (n = 71) | NS (n = 73) | CFCS (n = 40) | CS (n = 18) | RASopathy (n = 202) | iASD (n = 109) | |
|---|---|---|---|---|---|---|
| Participant demographics | ||||||
| Age of child (M (SD)) | 9.8 (4.37) | 9.2 (4.21) | 8.8 (4.10) | 11.0 (4.21) | 9.5 (4.26) | 10.4 (3.67) |
| Gender (N (%) male) | 36 (51) | 37 (51) | 17 (43) | 9 (50) | 99 (49) | 80 (73) |
| Race (N (%)) | ||||||
| American Indian or Alaska Native | 0 (0) | 1 (1) | 1 (3) | 0 (0) | 2 (1) | 5 (5) |
| Asian | 2 (3) | 4 (6) | 3 (8) | 2 (11) | 11 (5) | 5 (5) |
| Black or African American | 4 (6) | 3 (4) | 1 (3) | 0 (0) | 8 (4) | 5 (5) |
| Native Hawaiian or Other Pacific Islander | 1 (1) | 1 (1) | 0 (0) | 2 (11) | 4 (2) | 2 (2) |
| White | 65 (92) | 69 (95) | 37 (93) | 17 (94) | 188 (93) | 96 (88) |
| Other | 1 (1) | 1 (1) | 2 (5) | 2 (11) | 6 (3) | 6 (5) |
| Ethnicity (% Hispanic/Latinx) | 13 (18) | 4 (6) | 3 (8) | 1 (6) | 21 (10) | 15 (14) |
| Medical complications (N (%)) | ||||||
| Preterm birth | 6 (9) | 12 (16) | 13 (33) | 8 (44) | 39 (19) | 9 (8) |
| Seizures | 10 (14) | 7 (10) | 20 (50) | 2 (11) | 39 (19) | 1 (1) |
| Tumor | 31 (44) | 4 (6) | 1 (3) | 0 (0) | 36 (18) | 0 (0) |
| Visual impairment | 20 (29) | 37 (51) | 29 (73) | 12 (67) | 98 (49) | 20 (19) |
| Hearing impairment | 4 (6) | 16 (22) | 10 (25) | 0 (0) | 30 (15) | 2 (2) |